59 related articles for article (PubMed ID: 21749894)
21. Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management.
Cobaugh DJ; Erdman AR; Booze LL; Scharman EJ; Christianson G; Manoguerra AS; Caravati EM; Chyka PA; Woolf AD; Nelson LS; Troutman WG
Clin Toxicol (Phila); 2007 Dec; 45(8):918-42. PubMed ID: 18163235
[TBL] [Abstract][Full Text] [Related]
22. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
[TBL] [Abstract][Full Text] [Related]
23. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
[TBL] [Abstract][Full Text] [Related]
24. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.
Anderson BO; Shyyan R; Eniu A; Smith RA; Yip CH; Bese NS; Chow LW; Masood S; Ramsey SD; Carlson RW
Breast J; 2006; 12 Suppl 1():S3-15. PubMed ID: 16430397
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer.
Weinmann S; Taplin SH; Gilbert J; Beverly RK; Geiger AM; Yood MU; Mouchawar J; Manos MM; Zapka JG; Westbrook E; Barlow WE
J Natl Cancer Inst Monogr; 2005; (35):33-8. PubMed ID: 16287883
[TBL] [Abstract][Full Text] [Related]
27. Impact of a mailed intervention on annual mammography and physician breast examinations among women at high risk of breast cancer.
Richardson JL; Mondrus GT; Danley K; Deapen D; Mack T
Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):71-6. PubMed ID: 8770470
[TBL] [Abstract][Full Text] [Related]
28. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
29. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
30. CATCH-KB: Establishing a Pharmacogenomics Variant Repository for Chemotherapy-Induced Cardiotoxicity.
Morash M; Mitchell H; Yu A; Campion T; Beltran H; Elemento O; Pathak J
AMIA Jt Summits Transl Sci Proc; 2018; 2017():168-177. PubMed ID: 29888066
[TBL] [Abstract][Full Text] [Related]
31. [A need to specify that the article applies to adult patients].
Andersen GL
Tidsskr Nor Laegeforen; 2023 Sep; 143(13):. PubMed ID: 37753753
[No Abstract] [Full Text] [Related]
32. Cardiovascular Risk in Cancer Survivors.
Agmon Nardi I; Iakobishvili Z
Curr Treat Options Cardiovasc Med; 2018 Apr; 20(6):47. PubMed ID: 29705862
[TBL] [Abstract][Full Text] [Related]
33. Cardiotoxicity of Anticancer Therapeutics.
Dong J; Chen H
Front Cardiovasc Med; 2018; 5():9. PubMed ID: 29473044
[TBL] [Abstract][Full Text] [Related]
34. Cardio-Oncology: A Focused Review of Anthracycline-, Human Epidermal Growth Factor Receptor 2 Inhibitor-, and Radiation-Induced Cardiotoxicity and Management.
Domercant J; Polin N; Jahangir E
Ochsner J; 2016; 16(3):250-6. PubMed ID: 27660573
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy-induced cardiotoxicity in women.
Dempsey KS
Heart Fail Clin; 2011 Jul; 7(3):427-35. PubMed ID: 21749894
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy-induced cardiotoxicity in women.
Dempsey KS
Crit Care Nurs Clin North Am; 2008 Sep; 20(3):343-50. PubMed ID: 18644518
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.
Doyle JJ; Neugut AI; Jacobson JS; Grann VR; Hershman DL
J Clin Oncol; 2005 Dec; 23(34):8597-605. PubMed ID: 16314622
[TBL] [Abstract][Full Text] [Related]
39. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
